HIV infection

Pfizer, Gilead, GSK to dominate infectious disease market

The infectious disease market is projected to grow by 5.7% through 2029, with Pfizer, Gilead and GSK expected to be the dominant forces in this market.

Ben Adams Jul 20, 2023 9:45am

Theratechnologies’ ‘Champions’ showcases minority HIV patients

Mar 30, 2023 4:16am

AbbVie top TV drug ad spender in January

Feb 6, 2023 9:45am

ViiV Healthcare finds HIV stigma still stubbornly high

Dec 2, 2022 9:40am